Soma Pharmacy Blognews

Archive for September 19th, 2009

First Doses of Swine Flu Vaccine Coming Soon

Posted by: SomaNews on: 19 Sep, 2009

First Doses of Swine Flu Vaccine Coming Soon
The first 3.4 million doses of swine flu vaccine — all the FluMist nasal spray vaccine — will ship in early October. Some flu shots may be ready by then, too, with more on the way.

Heart Risk Factors Cut Life Span by 10 Years

Posted by: SomaNews on: 19 Sep, 2009

Heart Risk Factors Cut Life Span by 10 Years
A 50-year-old smoker who has a history of high blood pressure and high cholesterol can expect to die a decade earlier than someone of the same age with none of these heart disease risk factors, a study shows.

Ultrasound Eyebrow Lift Device OK’d

Posted by: SomaNews on: 19 Sep, 2009

Ultrasound Eyebrow Lift Device OK’d
The FDA has cleared a new ultrasound eyebrow lift device, called the Ulthera System, for use by doctors, according to the device’s maker.

2 Easiest Ways to Catch Swine Flu

Posted by: SomaNews on: 19 Sep, 2009

2 Easiest Ways to Catch Swine Flu
Aside from having someone cough on your face, the easiest way to get the flu is to touch your eyes, nose, or mouth with unwashed hands, a risk-analysis study suggests.

Teva Provides Update For QVAR

Posted by: SomaNews on: 19 Sep, 2009

Teva Provides Update For QVAR
Study demonstrates that QVAR is more cost-effective than other inhaled corticosteroid (ICS) asthma therapy options

InVitria Completes Beta Testing Of Optiferrin For Mammalian Cell Culture
Optiferrin shown to provide superior performance in cell culture

Genentech Provides Positive Data For Phase III Study For Rituxan
Study showed patients lived longer without low-grade lymphoma progressing when Rituxan was used as first-line treatment for maintenance

Ranbaxy In-licenses Cosmetic Product For Indian Market

Posted by: SomaNews on: 19 Sep, 2009

Ranbaxy In-licenses Cosmetic Product For indian Market
Botulinum Toxin Type -A, an anti-ageing medicine, is used in the correction of facial wrinkles and hyperhidrosis

Intarcia Initiates Enrollment Of ITCA 650 Phase 2 Diabetes Study
Byetta, an FDA-approved twice-daily injection form of exenatide

Bolder Receives $1.2m NIH Grant

Posted by: SomaNews on: 19 Sep, 2009

Bolder Receives $1.2m NIH Grant
For the development of long-acting EPO analog for chronic kidney disease


Categories

soma
ambien
duty free tobacco
Rolex Replica

Archives

 

September 2009
M T W T F S S
« Aug   Oct »
 123456
78910111213
14151617181920
21222324252627
282930